These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36686811)

  • 1. Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinoma.
    Wang N; Gaddam S; Xie Y; Christodoulou AG; Wu C; Ma S; Fan Z; Wang L; Lo S; Hendifar AE; Pandol SJ; Li D
    Front Oncol; 2022; 12():1007134. PubMed ID: 36686811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma.
    Wang N; Gaddam S; Wang L; Xie Y; Fan Z; Yang W; Tuli R; Lo S; Hendifar A; Pandol S; Christodoulou AG; Li D
    Magn Reson Med; 2020 Aug; 84(2):928-948. PubMed ID: 31961967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease.
    Wang L; Gaddam S; Wang N; Xie Y; Deng Z; Zhou Z; Fan Z; Jiang T; Christodoulou AG; Han F; Lo SK; Wachsman AM; Hendifar AE; Pandol SJ; Li D
    Front Physiol; 2020; 11():8. PubMed ID: 32153416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass: added value of magnetic resonance elastography.
    Liu Y; Wang M; Ji R; Cang L; Gao F; Shi Y
    Clin Radiol; 2018 Oct; 73(10):865-872. PubMed ID: 29895389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative 3D dynamic contrast-enhanced (DCE) MR imaging of carotid vessel wall by fast T1 mapping using Multitasking.
    Wang N; Christodoulou AG; Xie Y; Wang Z; Deng Z; Zhou B; Lee S; Fan Z; Chang H; Yu W; Li D
    Magn Reson Med; 2019 Apr; 81(4):2302-2314. PubMed ID: 30368891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation.
    Wang L; Zhou Z; Gaddam S; Wang N; Xie Y; Deng Z; Fan Z; Christodoulou AG; Han F; Lo SK; Wachsman AM; Hendifar AE; Jiang T; Pandol SJ; Li D
    Pancreas; 2022 May; 51(5):463-468. PubMed ID: 35858211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
    Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Contrast-Enhanced MRI Assessing Antifibrotic Therapeutic Effects of Pancreatic Fibrosis with Curcumin - An Experimental Study at 11.7 T.
    Lu Y; Zhang T; Yang S; Yang B; Li J; Liu H; Yao D; Ren G; Wang D
    Acad Radiol; 2023 Sep; 30 Suppl 1():S230-S237. PubMed ID: 37453883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective quantification of clinical abdominal DCE-MRI using pharmacokinetics-informed deep learning: a proof-of-concept study.
    Wu C; Wang N; Gaddam S; Wang L; Han H; Sung K; Christodoulou AG; Xie Y; Pandol S; Li D
    Front Radiol; 2023; 3():1168901. PubMed ID: 37731600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma.
    Tang W; Liu W; Li HM; Wang QF; Fu CX; Wang XH; Zhou LP; Peng WJ
    Eur J Radiol; 2019 Dec; 121():108734. PubMed ID: 31743881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
    Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
    Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Measuring Perfusion in Pancreatic Ductal Adenocarcinoma and Different Tumor Grade: A Preliminary Single Center Study.
    Zaborienė I; Strakšytė V; Ignatavičius P; Barauskas G; Dambrauskienė R; Žvinienė K
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing.
    Choi MH; Yoon SB; Lee YJ; Jung ES; Pak S; Han D; Nickel D
    Front Oncol; 2024; 14():1304187. PubMed ID: 38525415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
    Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiparameter magnetic resonance imaging for diagnosing and severity grading of chronic pancreatitis.
    Olesen SS; Steinkohl E; Hansen TM; Drewes AM; Frøkjær JB
    Abdom Radiol (NY); 2023 Feb; 48(2):630-641. PubMed ID: 36477631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.
    Kersting S; Konopke R; Kersting F; Volk A; Distler M; Bergert H; Saeger HD; Grützmann R; Bunk A
    Gastroenterology; 2009 Dec; 137(6):1903-11. PubMed ID: 19715694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.